852 related articles for article (PubMed ID: 19238142)
1. Serum adiponectin confers little protection against diabetes and hypertension in Turkish men.
Onat A; Hergenç G; Can G; Küçükdurmaz Z
Obesity (Silver Spring); 2009 Mar; 17(3):564-70. PubMed ID: 19238142
[TBL] [Abstract][Full Text] [Related]
2. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women.
Onat A; Hergenç G; Karabulut A; Albayrak S; Can G; Kaya Z
Metabolism; 2007 Oct; 56(10):1356-62. PubMed ID: 17884445
[TBL] [Abstract][Full Text] [Related]
3. Circulating adiponectin levels associate with inflammatory markers, insulin resistance and metabolic syndrome independent of obesity.
Hung J; McQuillan BM; Thompson PL; Beilby JP
Int J Obes (Lond); 2008 May; 32(5):772-9. PubMed ID: 18253163
[TBL] [Abstract][Full Text] [Related]
4. Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.
Xu A; Tso AW; Cheung BM; Wang Y; Wat NM; Fong CH; Yeung DC; Janus ED; Sham PC; Lam KS
Circulation; 2007 Mar; 115(12):1537-43. PubMed ID: 17389279
[TBL] [Abstract][Full Text] [Related]
5. Serum complement C3: a determinant of cardiometabolic risk, additive to the metabolic syndrome, in middle-aged population.
Onat A; Hergenç G; Can G; Kaya Z; Yüksel H
Metabolism; 2010 May; 59(5):628-34. PubMed ID: 19913840
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of prehypertension for metabolic syndrome, diabetes, and coronary heart disease among Turks.
Onat A; Yazici M; Can G; Kaya Z; Bulur S; Hergenç G
Am J Hypertens; 2008 Aug; 21(8):890-5. PubMed ID: 18551102
[TBL] [Abstract][Full Text] [Related]
7. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations.
Yasui T; Tomita J; Miyatani Y; Yamada M; Uemura H; Irahara M; Arai M; Kojimahara N; Okabe R; Ishii Y; Tashiro S; Sato H
Clin Chim Acta; 2007; 386(1-2):69-75. PubMed ID: 17825805
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
9. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults.
Ryu SY; Kim KS; Park J; Kang MG; Han MA
J Prev Med Public Health; 2008 Nov; 41(6):413-8. PubMed ID: 19037171
[TBL] [Abstract][Full Text] [Related]
10. Serum apolipoprotein B predicts dyslipidemia, metabolic syndrome and, in women, hypertension and diabetes, independent of markers of central obesity and inflammation.
Onat A; Can G; Hergenç G; Yazici M; Karabulut A; Albayrak S
Int J Obes (Lond); 2007 Jul; 31(7):1119-25. PubMed ID: 17299378
[TBL] [Abstract][Full Text] [Related]
11. Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.
Kazumi T; Kawaguchi A; Hirano T; Yoshino G
Horm Metab Res; 2006 Feb; 38(2):119-24. PubMed ID: 16523413
[TBL] [Abstract][Full Text] [Related]
12. Neck circumference as a measure of central obesity: associations with metabolic syndrome and obstructive sleep apnea syndrome beyond waist circumference.
Onat A; Hergenç G; Yüksel H; Can G; Ayhan E; Kaya Z; Dursunoğlu D
Clin Nutr; 2009 Feb; 28(1):46-51. PubMed ID: 19010573
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and metabolic syndrome in middle-aged and elderly Chinese.
Wang J; Li H; Franco OH; Yu Z; Liu Y; Lin X
Obesity (Silver Spring); 2008 Jan; 16(1):172-8. PubMed ID: 18223631
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and its correlates of cardiovascular risk in young adults: the Bogalusa Heart Study.
Patel DA; Srinivasan SR; Xu JH; Chen W; Berenson GS
Metabolism; 2006 Nov; 55(11):1551-7. PubMed ID: 17046560
[TBL] [Abstract][Full Text] [Related]
16. Further inflammatory information on metabolic syndrome by adiponectin evaluation.
Matsushita K; Tamakoshi K; Yatsuya H; Wada K; Otsuka R; Takefuji S; Hotta Y; Kondo T; Murohara T; Toyoshima H
Int J Cardiol; 2008 Mar; 124(3):339-44. PubMed ID: 17433469
[TBL] [Abstract][Full Text] [Related]
17. Serum γ-glutamyltransferase: independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease.
Onat A; Can G; Örnek E; Çiçek G; Ayhan E; Doğan Y
Obesity (Silver Spring); 2012 Apr; 20(4):842-8. PubMed ID: 21633402
[TBL] [Abstract][Full Text] [Related]
18. Discordance between insulin resistance and metabolic syndrome: features and associated cardiovascular risk in adults with normal glucose regulation.
Onat A; Hergenç G; Türkmen S; Yazici M; Sari I; Can G
Metabolism; 2006 Apr; 55(4):445-52. PubMed ID: 16546474
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, incidence, predictors and outcome of type 2 diabetes in Turkey.
Onat A; Hergenç G; Uyarel H; Can G; Ozhan H
Anadolu Kardiyol Derg; 2006 Dec; 6(4):314-21. PubMed ID: 17162275
[TBL] [Abstract][Full Text] [Related]
20. Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome.
Henneman P; Janssens AC; Zillikens MC; Frolich M; Frants RR; Oostra BA; van Duijn CM; van Dijk KW
J Intern Med; 2010 Apr; 267(4):402-9. PubMed ID: 19912464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
